AMN Healthcare Services (AMN)
(Delayed Data from NYSE)
$61.70 USD
+1.91 (3.19%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $61.00 -0.70 (-1.13%) 7:58 PM ET
5-Strong Sell of 5 5
A Value C Growth D Momentum B VGM
Income Statements
Fiscal Year end for AMN Healthcare Services Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,789 | 5,243 | 3,984 | 2,394 | 2,222 |
Cost Of Goods | 2,540 | 3,527 | 2,675 | 1,602 | 1,479 |
Gross Profit | 1,250 | 1,717 | 1,310 | 792 | 743 |
Selling & Adminstrative & Depr. & Amort Expenses | 911 | 1,070 | 832 | 643 | 567 |
Income After Depreciation & Amortization | 338 | 647 | 478 | 149 | 177 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 54 | 40 | 34 | 58 | 28 |
Pretax Income | 284 | 607 | 444 | 92 | 148 |
Income Taxes | 74 | 163 | 117 | 21 | 35 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 211 | 444 | 327 | 71 | 114 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 211 | 444 | 327 | 71 | 114 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 499 | 785 | 582 | 243 | 235 |
Depreciation & Amortization (Cash Flow) | 161 | 138 | 104 | 94 | 58 |
Income After Depreciation & Amortization | 338 | 647 | 478 | 149 | 177 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 39.34 | 44.87 | 48.05 | 47.69 | 47.59 |
Diluted EPS Before Non-Recurring Items | 8.21 | 11.90 | 8.03 | 3.43 | 3.18 |
Diluted Net EPS (GAAP) | 5.36 | 9.90 | 6.81 | 1.48 | 2.40 |
Fiscal Year end for AMN Healthcare Services Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 820.88 | 818.27 | 853.46 | 991.30 |
Cost Of Goods | NA | 563.37 | 557.32 | 563.96 | 661.02 |
Gross Profit | NA | 257.51 | 260.95 | 289.51 | 330.28 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 217.56 | 226.78 | 202.59 | 238.62 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 39.95 | 34.17 | 86.92 | 91.66 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 16.63 | 20.17 | 11.54 | 12.18 |
Pretax Income | NA | 23.32 | 14.00 | 75.39 | 79.49 |
Income Taxes | NA | 5.99 | 1.52 | 22.21 | 18.58 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 17.33 | 12.49 | 53.17 | 60.91 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 17.33 | 12.49 | 53.17 | 60.91 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 38.20 | 38.17 | 38.33 | 39.34 |
Diluted EPS Before Non-Recurring Items | NA | 0.97 | 1.32 | 1.97 | 2.38 |
Diluted Net EPS (GAAP) | NA | 0.45 | 0.40 | 1.39 | 1.55 |